The presence of Ms. CD30L in serum, plasma, or cell culture medium of mice is quantified by L-ELISA CD30L (TNFSF8). The assay will recognize only CD30L of both natural and recombinant mice. Method principle The ELISA test...
The presence of Ms. CD30L in serum, plasma, or cell culture medium of mice is quantified by L-ELISA CD30L (TNFSF8). The assay will recognize only CD30L of both natural and recombinant mice. Method Principle The ELISA solid phase sandwich test for mouse CD30L (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
The ligand for CD30 is CD30L (CD153). The CD30-CD30L bond allows for the mediating of pleiotropic effects, including cell proliferation, activation, differentiation and apoptotic cell death. CD30 plays an essential role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulation molecule in the negative thymic selection. In addition to its expression in Hodgkin and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin lymphomas (including Burkitt lymphomas), virus-infected T and B cells, and normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells that produce Th2 cytokines and on thymocytes of CD4+/CD8+ that coexpress CD45RO and IL4 receptors.
Sensitivity
Sensitivity of dosage: 0.6 ng/ml.
Measurement range
Dose range: 0.41 to 100 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Sample volume: Plasma, 50 µl; serum, 50 µl; supernatant, 100 µl.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17115799 |
| Specifications |
| Accession number | CD153; CD153 antigen; CD30 antigen ligand; CD30 ligand; Cd30l; CD30-L; CD30LG; CD30ligand; Tnfsf8; TNLG3A; member of the superfamily (ligand) of tumour necrosis factor 8; superfamily (ligand) of tumour necrosis factor 8; ligand of tumour necrosis factor 3A; member of the |
| Dose range | 0.41 to 100 pg/ml |
| Sensitivity of the dosage | 0.6 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P32972 |
| Gene symbol(s) | Tnfsf8 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96-well pre-coated plate Standard Concentrate of dosing diluent Biotinylated detection antibody SAV-HRP Wash pad Chromogen Discontinue solution Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | CD153 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 µl; serum, 50 µl; supernatant, 100 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EMTNFSF8X5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.